A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.

Not Applicable

Completed

• Conditions: pH

• Registration Number: NCT06122597
• Lead Sponsor: Trace Minerals

Brief Summary

This virtual single-arm trial will last 12 weeks. Participants will take the drops daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12.

Urine pH measurements will be taken at Baseline, Week 4, Week 8, and Week 12 using pH test strips.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-05
• Study First Submitted: 2023-11-02
• Study First Submitted QC: 2023-11-02
• Study First Posted: 2023-11-08
• Primary Completion: 2024-01-31
• Study Completion: 2024-01-31
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-21
• Last Update Posted: 2024-08-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Male or female. Aged 18+. Generally healthy - don't live with any uncontrolled disease. Willing to maintain their standard dietary pattern, activity level, and body weight for the duration of the study.

Exclusion Criteria

• Anyone with a pre-existing chronic condition that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.

Anyone with known severe allergic reactions. Women who are pregnant, breastfeeding, or attempting to become pregnant. Anyone unwilling to follow the study protocol.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Changes in urine pH levels. [Timeframe: Baseline to Week 12]	12 weeks	Participants will use pH test strips to measure urine pH. Changes in urine pH will be evaluated.

Secondary Outcome Measures

Name	Time	Method
Change in score on the Metabolic Screening Questionnaire.	12 weeks	A Metabolic Screening Questionnaire (MSQ) was developed by the Toronto Centre for Naturopathic Medicine. The symptoms represented on a MSQ represent symptoms commonly associated with inflammation and toxicity. Participants will rate frequency and intensity of applicable symptoms according to the following scores: * Absent or rare symptoms - 0 points; * Occasional, mild symptoms - 1 point; * Occasional, severe symptoms - 2 points; * Frequent, mild symptoms - 3 points; * Frequent, severe symptoms - 4 points

Trial Locations

Locations (1)

Citruslabs; 🇺🇸 Santa Monica, California, United States